The human T cell leukemia virus type I (HTLV-I) is an oncogenic retrovirus that is etiologically linked to the genesis of adult T cell leukemia (ATL) as well as HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Emerging evidence suggests that the pathogenicity of HTLV-I involves deregulated activation of immune cells, especially T lymphocytes, although the underlying mechanism remains unclear. In this study, we demonstrate that HTLV-I Tax induces the aberrant expression of CD40, a member of the tumor necrosis factor receptor (TNFR) family that plays an important role in lymphocyte activation and differentiation. In a panel of HTLV-I-transformed T cell lines analyzed, CD40 expression was highly elevated compared to HTLV-I-negative T cells. Using Tax mutants and a genetically manipulated T cell system, we demonstrated that Tax-induced CD40 expression required the NF-nB signaling pathway. In addition, ligation of CD40 on T cells with recombinant CD40L elicited NF-nB activation, suggesting that the CD40 pathway is intact and may participate in a positive regulatory loop in T cells. CD40 ligation strongly synergized with Tax to activate NF-nB, suggesting that CD40 signals may costimulate Tax-mediated NF-nB activation, particularly when Tax is expressed at low levels. Collectively, these results indicate that CD40 is a novel Tax-regulated gene, and the regulation of CD40 by Tax may play a role in cellular activation and HTLV-I-induced disease pathogenesis.
Introduction
Human T cell leukemia virus type I (HTLV-I) is the etiologic agent of an aggressive malignancy known as adult T cell leukemia (ATL) and a demyelinating neurological disorder referred to as HTLV-I associated myelopathy/ tropical spastic paraparesis (HAM/TSP) (Grant et al., 2002; Miyoshi et al., 1981; Osame et al., 1986; Poiesz et al., 1980) . The pX region of the HTLV-I genome encodes several regulatory and accessory viral proteins, including the trans-activating protein Tax that is essential for viral gene expression and replication (Franklin and Nyborg, 1995; Yao and Wigdahl, 2000) . Tax is negatively regulated by an additional viral protein, encoded in open reading frame II (ORF-II) of the pX region, known as p30 II (Albrecht and Lairmore, 2002) . p30
II acts as a posttranscriptional negative regulator of viral replication by retaining doubly spliced mRNA encoding Tax and Rex in the nucleus, thus resulting in a specific reduction of both Tax and Rex protein (Nicot et al., 2004) . Tax modulates the expression of cellular genes that impact cellular activation, survival, growth, and transformation (Ballard et al., 1988; de La Fuente et al., 2000; Ng et al., 2001; Pise-Masison et al., 2002; Yoshida, 2001) . The effect of Tax on cellular gene expression is primarily mediated by the activation of cellular signaling cascades and transcription factors. One well-defined target transcription factor of Tax is NF-nB/Rel, a family of enhancer binding proteins that play a central role in cell growth and survival (Barkett and Gilmore, 1999; Jeang, 2001; Sun and Ballard, 1999) . The mammalian NF-nB is composed of five subunits, RelA (p65), p50, c-Rel, p52, and RelB, which form various homo-and hetero-dimeric protein complexes (Rothwarf and Karin, 1999) . The NF-nB proteins all contain a Rel homology domain (RHD) that has been shown to confer DNA binding, nuclear localization, and dimerization properties. NF-nB is held inactive in the cytosol by a family of inhibitory proteins known as InBs that mask the nuclear localization signals of NF-nB (Beg et al., 1992) . NF-nB agonists, such as the cytokines TNF-a and IL-1, activate NF-nB by inducing the activity of an InB kinase (IKK) which is composed of two catalytic subunits, IKKa and IKKh, and a regulatory component, IKKg (Zandi et al., 1997) . The activated IKK phosphorylates InBs, triggering their proteolysis through the ubiquitin/proteasome pathway, which facilitates nuclear import of NF-nB and activation of target genes (Karin, 1999) . The IKK regulatory subunit IKKg is essential for activation of IKK and NF-nB by cytokines and Tax (Harhaj et al., 2000; Makris et al., 2000; Yamaoka et al., 1998) . Tax constitutively activates the IKK complex in HTLV-I-infected T cells by a mechanism involving physical interaction with IKKg (Chu et al., 1999; Jin et al., 1999) .
CD40 is a member of the tumor necrosis factor receptor (TNFR) family and is expressed on a wide variety of cell types including B cells, dendritic cells (DCs), macrophages, endothelial cells, and neurons (van Kooten and Banchereau, 2000) . The ligand for CD40 (CD40L) is primarily expressed on activated T lymphocytes and interacts with CD40 to orchestrate humoral and cellular immune responses. Engagement of CD40 on B cells leads to cell proliferation, differentiation, and immunoglobulin (Ig) isotype class switching (Foy et al., 1996) . Ligation of CD40 on DCs acts as a potent maturation signal by mediating increased expression of MHC and costimulatory molecules (Caux et al., 1994; Cella et al., 1996; Schuurhuis et al., 2000) . CD40 and CD40L null mice exhibit profound defects in Ig isotype class switching, germinal center formation, B cell activation, and antigen-specific T cell priming (Grewal et al., 1995; Kawabe et al., 1994; Xu et al., 1994) . In addition, patients with hyper-IgM syndrome harbor mutations in either CD40L or CD40 that result in impaired interactions of CD40 and CD40L and lead to defective T cell responses and a lack of Ig isotype class switching (Aruffo et al., 1993; Bhushan and Covey, 2001) . Signaling through CD40 activates a variety of signaling cascades including the NFnB pathway (Berberich et al., 1994; Francis et al., 1995; O'Sullivan and Thomas, 2002) , and CD40-mediated NF-nB activation is critical for the induction of primary response genes required for B cell activation (Dadgostar et al., 2002) .
HTLV-I infection deregulates the expression of several members of the TNF and TNFR families such as OX40, OX40L, CD30, TNF-a, and LT-h Higashimura et al., 1996; Pankow et al., 2000; Paul et al., 1990; Pise-Masison et al., 2002) . It is likely that altered expression of these proteins enhances both cell survival and costimulation of immune responses. Interestingly, HTLV-I modulates the expression of CD40L in infected T cells in a disease-specific manner. HTLV-I-infected patients with ATL lack expression of CD40L on CD4 + T cells, but those with HAM/TSP exhibit prolonged CD40L expression on CD4 + T cells in vitro (Makino et al., 2001 ). Therefore, sustained expression of CD40L coincides with hyper-stimulated immune responses in HAM/TSP, and lack of CD40L is associated with immunosuppression that is a characteristic feature of ATL patients. The receptor for CD40L, CD40, is expressed on the cell surface of HTLV-Iinfected cells (Dezzutti et al., 1995) , although the role of Tax in CD40 expression and also the functional effects of CD40 expression within T cells are unknown. In this report, we demonstrate that HTLV-I and Tax modulate the expression of several TNF/TNFR genes, including CD40 in T lymphocytes. CD40 is normally not expressed in T cells, although its expression is increased in T cells associated with specific pathogenic states such as diabetes (Wagner et al., 2002) . Tax upregulates CD40 expression by activating the NF-nB pathway. CD40 expression on T cells may participate in a positive regulatory loop by activation of transcription factors such as NF-nB and may be involved in HTLV-I-mediated immune dysfunction and disease pathogenesis.
Results

Deregulation of TNF/TNFR genes by HTLV-I Tax
Previous studies by our laboratory and others have demonstrated that HTLV-I and Tax deregulate the expression of a wide array of cellular genes involved in activation, growth, and apoptosis (de La Fuente et al., 2000; Ng et al., 2001; Pise-Masison et al., 2002) . In order to more fully define genes of the TNF/TNFR superfamilies that are deregulated by Tax, we performed gene array analysis with a commercially available kit containing membranes spotted with cDNAs representing 23 different TNF/TNFR members as well as two housekeeping genes (GEArray Original Series Human TNF and TNFR Superfamily Gene Array; SuperArray). For a complete listing of all of the genes on the array, see www.superarray.com. Sup-T1 T cells were infected with recombinant retroviruses using supernatants from 293 cells transfected with retroviral vectors encoding either an empty vector (pCLXSN) or Tax (pCLXSN-Tax). Total RNA from infected cells was converted into cDNA probes and hybridized to membranes for gene array analysis. Tax mRNA was readily detectable by RT-PCR in SUP-T1 cells infected with Tax but not the empty vector (data not shown). Tax deregulated the expression of several genes within the TNF and TNFR superfamilies ( Fig. 1 and Table 1 ). In agreement with previous studies, Tax induced the expression of both OX40 (Higashimura et al., 1996) and OX40L (Ohtani et al., 1998; Pise-Masison et al., 2002) (Table 1) . Tax also mediated the induction of CD40, CD40L, Fas, CD27, and CD30. Interestingly, Tax induction of CD40 mRNA was strongest of all the genes on the array. It has been previously demonstrated that HTLV-I infection may regulate the expression of CD30 , CD40L (Makino et al., 2001) , and CD40 (Dezzutti et al., 1995) . Only one gene, lymphotoxin-a, was down-regulated by Tax (Table 1) . Importantly, the levels of the housekeeping genes h-actin (3G, 4G) and GAPDH (5G, 6G, 7G, 8E, 8F and 8G) were unaltered by the expression of Tax (Fig. 1 ). The remainder of our studies was focused on characterization of CD40 as a Tax-regulated gene and potential functional outcomes of CD40 ligation on T cells.
CD40 expression is upregulated by Tax in HTLV-I-infected T cell lines
Although the expression of cell surface CD40 on HTLV-I-infected T cell lines has been previously noted (Dezzutti et al., 1995) , it is unclear how and why CD40 is induced by HTLV-I. To verify that CD40 was indeed overexpressed in HTLV-I-infected T cell lines, we examined mRNA levels of CD40 in a panel of HTLV-I-infected T cell lines and uninfected negative controls. There was a striking correlation between HTLV-I infection and CD40 mRNA expression. CD40 mRNA was readily detected in the four HTLV-I-infected T cell lines examined ( Fig. 2A, lanes 3-6) , but not in the HTLV-I-negative control cell lines, Jurkat and SUP-T1 (lanes 1 and 2). As expected, only the HTLV-Iinfected T cell lines expressed Tax, and the levels of the housekeeping gene GAPDH were comparable between all cell lines examined ( Fig. 2A) . The cell surface expression levels of CD40 were next examined in each of the cell lines by flow cytometry. As expected, all of the HTLV-I-infected cell lines expressed CD40 on the cell surface (Fig. 2B) , while the uninfected Jurkat and SUP-T1 cell lines did not express any CD40 on the cell surface (Fig. 2B) . These results indicate that HTLV-I infection induces the expression of CD40 on T cells.
The HTLV-I Tax gene product is the primary viral trans-activator protein which modulates both viral and cellular gene expression. Our gene array study suggested that Tax was responsible for the induction of CD40 in T cells. To confirm the gene array results, retroviral vectors Fig. 1 . Deregulation of TNF/TNFR genes by HTLV-I Tax. Gene array analysis was performed with mRNA from Tax-infected SUP-T1 cells or control-infected SUP-T1 cells. SUP-T1 cells were infected with recombinant retroviruses from 293 cells infected with either an empty vector (pCLXSN) or a retroviral vector encoding Tax (pCLXSN-Tax). Five days after infection, total RNA was isolated and subjected to gene array analysis using the GEArray Original Series TNF and TNFR Superfamily Gene Array Kit. Individual genes were spotted in duplicate on the membrane. The gene array membrane on the left was probed with cDNA from SUP-T1 cells infected with an empty vector (control), and the gene array on the right was probed with cDNA from SUP-T1 cells infected with Taxexpressing retroviruses (Tax). The boxed region represents duplicate spots of the CD40 gene. Individual spots were quantitated for direct comparison between the two arrays. Genes found to be deregulated by Tax at least 1.5-fold are listed in Table 1 . encoding either empty vector, Tax (Rivera-Walsh et al., 2001 ), Tax M22, or Tax M47 were used to infect either Jurkat or SUP-T1 cells. Tax M22 and M47 represent point mutations that allow segregation of Tax function; M22 has a specific defect in NF-nB activation whereas M47 has a specific defect in the CREB activation pathway (Smith and Greene, 1990) . The expression of Tax was determined to be less cytotoxic to SUP-T1 cells compared to Jurkat cells (data not shown), therefore experiments were primarily performed with SUP-T1 cells. SUP-T1 cells infected with supernatant from 293 cells transfected with Tax, Tax M22, and Tax M47 retroviral vectors expressed similar levels of Tax mRNA (Fig. 3A , lanes 2-4). Interestingly, only Tax and Tax M47 were able to induce CD40 mRNA (Fig. 3A , lanes 1-4), suggesting that the NF-nB pathway was required. The levels of GAPDH were similar in all of the indicated samples (Fig. 3A) .
Tax is a potent activator of the NF-nB transcription factor and activates the expression of numerous cellular genes via the NF-nB pathway. To further investigate the role of NFnB in Tax-mediated CD40 gene expression, we used a Jurkat mutant cell line (JM4.5.2) defective in NF-nB signaling due to the lack of IKKg (Harhaj et al., 2000) .
Reintroduction of IKKg, but not GFP, in these cells was able to fully revert the mutant phenotype (Harhaj et al., 2000; Rivera-Walsh et al., 2000) . We performed retroviral infections of Tax in JM4.5.2 cells expressing either GFP or IKKg. Expression of Tax in IKKg but not GFP-expressing mutant cells was able to induce CD40 expression (Fig. 3B , lanes 5 and 6). Collectively, these results indicate that CD40 is a Tax-regulated gene whose expression requires NF-nB activation.
Activation of the CD40 promoter by Tax
Since Tax is a potent trans-activating protein, it is likely that Tax induces CD40 expression at the transcriptional level. Previous studies have identified four putative NF-nB sites in the upstream region of the CD40 promoter that play a role in response to lipopolysaccharide (LPS) and interferon-gamma (IFN-g) in B cells and macrophages, respectively (Nguyen and Benveniste, 2002; Tone et al., 2002 ). An additional study indicated that the promoterproximal NF-nB site was essential for CD40 promoter activation by overexpressed NF-nB in COS-7 cells (Hinz et al., 2001 ). In addition to NF-nB sites, there are also three GAS elements, juxtaposed to three NF-nB sites, that bind to STAT factors (Nguyen and Benveniste, 2000) (Fig. 4A ). There are also 2 Sp1 sites proximal to the start site (Fig.  4A ). To determine if Tax was able to activate the CD40 promoter, 747 nucleotides of the CD40 upstream region were cloned into pGL3 to direct the expression of a firefly luciferase reporter gene. Notably, all four NF-nB sites are located within this region (Fig. 4A) . Expression of Tax, but not the empty vector, activated the CD40 promoter in Jurkat T cells (Fig. 4B ). In addition, Tax M22, defective in NF-nB activation, was unable to effectively activate the CD40 promoter but was still proficient at activating the HTLV-I LTR (Fig. 4B) . Tax M47, which can activate NF-nB, but not CREB/ATF, was able to activate the CD40 promoter at levels similar to wild type (Fig. 4B ). These results suggest that Tax activates the CD40 promoter in an NF-nBdependent manner.
To localize the precise regions of the CD40 promoter necessary for Tax-mediated activation, several deletion mutants were constructed (Fig. 4C) . Of note, pGL3-CD40(À544) lacks the most distal NF-nB site (NF-nB1). pGL3-CD40(À427), (À327), and (À198) lack the three most distal NF-nB sites (NF-nB1, NF-nB2, and NF-nB3), and pGL3-CD40(À56) lacks all four NF-nB sites. Tax activated all of the CD40 reporter deletion constructs with similar efficiency with the exception of À56, suggesting that the Tax-responsive element in the CD40 promoter resided between À198 and À56 (Fig. 4C) . Importantly, the proximal NF-nB site (NF-nB4) resides within this region. To determine whether NF-nB4 was essential for Tax-mediated activation of the CD40 promoter, site-directed mutagenesis was performed in the context of pGL3-CD40 (À747) to abrogate the NF-nB site. The mutation was targeted to the 3V end of the NF-nB site in order to leave the adjacent GAS element intact. When NF-nB4 was mutated, Tax-mediated activation of the CD40 promoter was significantly reduced (Fig. 4D) . Interestingly, the basal levels of the CD40 promoter were increased when NF-nB4 was mutated (Fig.  4D ), indicating that NF-nB may repress the basal levels of the CD40 promoter. Regardless, Tax requires the proximal NF-nB element (NF-nB4) for optimal activation of the CD40 promoter. Notably, this site was found to be essential for CD40 promoter activation by overexpressed NF-nB in COS-7 cells (Hinz et al., 2001) .
Activation of T cells by the phorbol ester PMA and the calcium ionophore ionomycin leads to activation of IKK and NF-nB (Harhaj et al., 2000) . Due to the importance of NF-nB in Tax-mediated regulation of CD40 expression, the effect of combined treatment with PMA and ionomycin on the activation of the CD40 promoter was examined. Surprisingly, PMA and ionomycin stimulation was unable to activate the CD40 promoter despite the presence of four putative NF-nB elements (Fig. 4E) . However, combined stimulation with these agents was a potent activator of the control NF-nB reporter (Fig. 4E) . Stimulation of primary human peripheral blood T cells or Jurkat T cells with PMA and ionomycin similarly failed to induce CD40 mRNA or protein expression (data not shown). These results suggested that NF-nB was required, but not sufficient, for Tax-induced CD40 gene expression. It was also possible that Tax may have activated NF-nB subunits that were distinct from those induced by mitogens.
HTLV-I and Tax elicit NF-jB subunit binding to the proximal CD40 NF-jB element
The next objective was to determine if HTLV-I infection elicited NF-nB binding to the proximal NF-nB element (NF-nB4) in the CD40 promoter. EMSA was performed with double-stranded oligonucleotides representing the NFnB4 element. Protein complexes bound to the NF-nB4 site were detected with nuclear extracts derived from all of the HTLV-I-infected cell lines examined, but not the control uninfected cells (Fig. 5A, lanes 1-6) . However, when Jurkat cells were stimulated with PMA and ionomycin for 30 min or 6 h, NF-nB complexes were detected (Fig. 5A, lanes 7-9) . The specificity of DNA-protein complex formation was determined by competition studies with unlabeled competitors. As expected, a 50-fold molar excess of bcoldQ CD40 NF-nB4 double-stranded oligonucleotide or a consensus NF-nB site from the IL-2Ra promoter effectively competed with the labeled probe and eliminated binding of nuclear 8) were subjected to competition analysis with a 50-fold molar excess of unlabeled double-stranded oligonucleotides representing the CD40 NFnB4 site (lanes 2 and 6), a mutant CD40 NF-nB4 site (lanes 3 and 7) , or a consensus NF-nB site from the IL-2Ra promoter (lanes 4 and 8) . The indicated unlabeled oligonucleotides were incubated with nuclear extracts for 20 min on ice prior to binding reactions. (C) Nuclear extracts from either C8166 (lanes 1-6), MT-2 (lanes 7-12) or Jurkat cells treated with PMA and ionomycin for 6 h (lanes 13-18) were subjected to supershift assays with either no antibody (lanes 1, 7, and 13), anti-RelA (p65; lanes 2, 8, and 14), anti-p50 (lanes 3, 9, and 15), anti-c-Rel (lanes 4, 10, and 16), anti-p52 (lanes 5, 11, and 17), or anti-control rabbit Ig (lanes 6, 12, and 18). The indicated antibodies were incubated with nuclear extracts for 20 min on ice prior to binding reactions. extracts from both C8166 and MT-2 cells (Fig. 5B, lanes 1,  2, 4 , 5, 6, and 8). Although a GAS element overlaps this NF-nB site, the IL-2Ra NF-nB site was able to compete away the protein-DNA complex (Fig. 5B) , suggesting that only NF-nB proteins bind to the CD40 NF-nB4 DNA probe. An unlabeled mutant CD40 NF-nB4 probe was unable to compete with a labeled wild-type probe (Fig. 5B, lanes 1, 3,  5, and 7) . The exact composition of the transcription factor DNA-protein complexes in HTLV-I-infected cells and activated Jurkat cells was ascertained by supershift analysis. Supershift reactions performed using C8166 and MT-2 nuclear extracts revealed that p50 and c-Rel were the predominant components of the NF-nB complexes (Fig.  5C ). This observation was consistent with other studies demonstrating that c-Rel, and not RelA, was the predominant NF-nB trans-activating protein in HTLV-I-infected T cells (Lanoix et al., 1994) . We also observed that Tax expression alone (Tax was expressed via a retroviral vector in SUP-T1 cells) elicited binding to the proximal CD40 probe with p50 and c-Rel also being the predominant NFnB proteins (data not shown). Supershift analyses performed with Jurkat cells indicated that RelA and p50 were the major NF-nB factors induced after 6 h (Fig. 5C , lanes 13-18) and after a 30-min treatment with PMA and ionomycin (data not shown). These results suggested that HTLV-I infection resulted in binding of NF-nB dimers, consisting of c-Rel and p50, to the proximal NF-nB element (NF-nB4) of the CD40 promoter. Stimulation of Jurkat cells with mitogens activated a distinct subset of NF-nB complexes comprised primarily of RelA and p50. Kooten and Banchereau, 2000) . In multiple cell types, a major target of CD40 signaling is NF-nB, which induces the expression of select target genes to mediate effector function (Dadgostar et al., 2002) . However, it is not clear if the CD40 signaling pathway is intact and functional in T lymphocytes. To address this question, Jurkat T cells were infected with retroviral vectors encoding CD40, GFP, or an empty vector. After 2 weeks of G418 selection, the bulk population of infected cells was subjected to flow cytometry to examine the expression of cell surface CD40. Jurkat cells infected with CD40, but not an empty vector or GFP (data not shown), exhibited abundant cell surface CD40 expression (Fig. 6A ). Jurkat-GFP or Jurkat-CD40 cells were stimulated with recombinant CD40L and activation of NF-nB was examined by InBa degradation and EMSA. CD40L stimulation had no effect on either InBa degradation or NF-nB DNA binding to a consensus NF-nB site in Jurkat-GFP cells (Figs. 6B and C,  lanes 1-3) . However, CD40L elicited both InBa degradation and NF-nB activation in Jurkat-CD40 cells (Figs. 6B  and C, lanes 4-6) . To examine the functional significance of CD40L stimulation of T cells, Jurkat-GFP or Jurkat-CD40 cells were transfected with an NF-nB reporter plasmid and increasing amounts of a Tax expression vector, and either treated with CD40L for 8 h or left untreated. Interestingly, CD40 ligation strongly synergized with suboptimal levels of Tax to activate NF-nB in Jurkat-CD40 but not Jurkat-GFP cells (Fig. 6D, right panel) . CD40L alone generally activated NF-nB in Jurkat-CD40 cells by about 10-20-fold and did not activate NF-nB in Jurkat-GFP cells (data not shown). Together, these results indicated that CD40L stimulation of T cells bearing the CD40 receptor leads to functional activation of NF-nB.
CD40 engagement activates NF-jB in T cells
CD40 serves distinct roles in different cell types including Ig isotype class switching in B cells and maturation of DCs (van
Discussion
In this study, we have demonstrated that (1) Tax deregulates the expression of multiple TNF/TNFR genes, including CD40; (2) CD40 mRNA and protein are upregulated in HTLV-I-infected T cell lines; (3) the HTLV-I Tax protein is sufficient to induce the expression of CD40 in HTLV-I-negative T cells; (4) Tax requires the NF-nB signaling pathway to activate CD40 gene expression and also to activate the CD40 promoter; and (5) engagement of CD40 on T cells by CD40L synergizes with suboptimal levels of Tax to activate NF-nB. This is the first report to demonstrate that CD40 gene expression is regulated by Tax. There are several potential functional effects of CD40 expression on T cells. CD40 engagement by CD40L leads to cellular activation, cytokine production and Ig isotype class switching in B cells, and maturation and cytokine production in DCs (Foy et al., 1996; van Kooten and Banchereau, 2000) . Previous studies have suggested that CD40 expressed on T cells may stimulate T cell activation and proliferation following stimulation with recombinant CD40L (Armitage et al., 1993) . However, resting T cells typically express low to undetectable levels of CD40, and activation of primary peripheral blood T cells with mitogens did not result in a significant induction of CD40, although CD40L was strongly induced (data not shown). It has been demonstrated that expression of CD40 on CD4 + T cells defines a highly activated and pathogenic population of cells that may mediate autoimmune disease (Wagner et al., 2002) . Furthermore, another report has suggested that CD40 expressed on mouse CD8 + T cells may mediate CD4 + T cell help through CD40L independent of APCs (Bourgeois et al., 2002) . Thus, under certain circumstances, CD40 expressed on T cells may regulate T cell activation or effector function upon encountering CD40L-expressing cells. Another potential effect of CD40 expression is down-regulation of CD40L on HTLV-I-infected T cells from ATL patients. Binding of CD40 on B cells by CD40L on T cells triggers receptormediated endocytosis and degradation of CD40L, a mechanism ensuring transient expression of CD40L (Yellin et al., 1994) . This regulation has been exploited by multiple 1-3) or CD40 (lanes 4-6) were either untreated or stimulated with CD40L as described above. Nuclear extracts (4 Ag) were subjected to EMSA with an NF-nB consensus probe. Non-specific DNA-protein complexes (ns). (D) Jurkat-GFP (1 Â 10 6 ) and Jurkat-CD40 cells (1 Â 10 6 ) were transfected with an NF-nB reporter plasmid (nB-TATA Luc; 0.2 Ag) in the absence or presence of increasing amounts of a Tax expression vector (pCMV4-Tax) using FuGENE 6. Cells were either left untreated or treated with recombinant CD40L (2 Ag/ml) for 8 h prior to harvesting the extracts which were read with a luminometer. The fold induction represents the fold difference of each sample relative to the untreated empty vector control. The experiment is representative of three independent experiments. carcinoma cell types that express CD40 and down-regulate CD40L on activated T cells as a strategy to avoid immune responses (Batrla et al., 2002) . Indeed, it has been shown that HTLV-I-infected T cells from ATL patients do not express CD40L, an event that may contribute to immune evasion and immune suppression (Makino et al., 2001) . It is possible that engagement of CD40 on HTLV-I-infected T cells may also stimulate the down-regulation of CD40L on activated T cells in an intra-or intercellular fashion. This possibility is currently being explored with primary T cells and also with JPX-9 cells, a Jurkat cell line that expresses Tax in an inducible manner.
The NF-nB family of transcription factors plays an important role in the regulation of CD40 expression. Murine embryonic fibroblasts (MEFs) lacking RelA are defective in the induction of CD40 following stimulation with LPS or cytokines (Ouaaz et al., 1999) . Furthermore, bone marrowderived DCs from RelBÀ/À mice lack cell surface CD40 expression, and DCs generated from wild-type mice in the presence of a chemical inhibitor of NF-nB nuclear translocation similarly lack CD40 expression (Martin et al., 2003) . Other studies have demonstrated the importance of NF-nB in the regulation of CD40 expression by LPS (Tone et al., 2002) , IFNg (Nguyen and Benveniste, 2002) , and in Hodgkin/Reed-Sternberg cells (Hinz et al., 2001 ). However, nothing is known regarding the regulation of CD40 expression in T cells. Our results suggest that NF-nB is essential for Tax-mediated CD40 induction in T cells, and the proximal NF-nB site (NF-nB4) appears to play an important role.
Our results suggest that CD40 may participate in a positive regulatory loop initiated by Tax in HTLV-I-infected T cells. Tax upregulates the expression of CD40 and other cell surface molecules which can then potentially synergize with Tax to sustain an NF-nB response. A previous study has indicated that overexpression of CD40 is sufficient to activate NF-nB (Rothe et al., 1995) . However, we did not observe constitutive NF-nB activation in Jurkat cells stably expressing CD40 (Fig. 6) , thus interaction with CD40L may be necessary for CD40-mediated NF-nB activation in T cells. In addition, it is not certain if the NF-nB factors induced by CD40 engagement are able to activate CD40 gene expression in T cells. Future studies will more precisely examine the mechanisms and downstream events mediated by CD40 signaling in T cells.
CD40 expression has been associated with a wide variety of malignancies affecting hematopoietic cells such as B cell lymphoma (Pham et al., 2002) , cutaneous T cell lymphoma (Storz et al., 2001) , and Hodgkin/Reed-Sternberg cells (Hinz et al., 2001) . Curiously, CD40 expression is also upregulated in nonhematopoietic neoplasms such as breast (Hirano et al., 1999) and hepatocellular carcinoma (Sugimoto et al., 1999) , squamous cell cancer of the head and neck (Posner et al., 1999) , as well as melanoma (von Leoprechting et al., 1999) . It has therefore been proposed that CD40 may play a role in cell growth or survival and contribute to the tumorigenic process. Although CD40 engagement on normal B cells leads to cell growth and differentiation, engagement of CD40 on malignant CD40 + cells primarily induces growth arrest and apoptosis (Hess and Engelmann, 1996; Hirano et al., 1999; Pham et al., 2002) . Thus, targeting tumors with agonistic CD40 antibodies or soluble CD40L may prove to be of therapeutic value. Indeed, results from a recent phase 1 clinical trial suggest that recombinant CD40L administered to patients with solid tumors or non-Hodgkin's lymphoma displays encouraging anti-tumor activity (Vonderheide et al., 2001 ). It will be of interest to determine if CD40 engagement on HTLV-I-infected T cells affects cell growth and viability.
Future studies will focus on additional molecular mechanisms employed by Tax to activate CD40 gene expression in T cells. Although NF-nB clearly plays an important role in Tax-mediated induction of CD40, the contribution of specific subunits needs to be more precisely defined. Gene silencing of individual subunits by short inhibitory RNAs (siRNA) will facilitate these studies. In addition, the potential role of other transcription factors and coactivators will be similarly examined. Pharmacologic inhibition of NF-nB as well as other signaling pathways may also be used to determine the role of other signaling molecules targeted by Tax to activate CD40 gene expression. Understanding how Tax activates CD40 gene expression in T cells will elucidate strategies used by a retroviral trans-activating protein to circumvent the normal regulation of cell-type specific expression and silencing of genes.
Materials and methods
Biological reagents and cell culture
The human T cell lymphocytic cell lines Jurkat and SUP-T1, and the HTLV-I-transformed T cell lines C8166, MT-2, SLB-1, and HUT-102, were cultured and maintained in RPMI 1640 medium. The IKKg-deficient Jurkat cell line (JM4.5.2) stably transfected with GFP (JM4.5.2-GFP) or IKKg (JM4.5.2-IKKg) was cultured in RPMI medium containing G418 (1 mg/ml; Invitrogen, Carlsbad, CA). Human embryonic kidney 293 cells were cultured in DMEM medium. All media formulations were supplemented with 10% heat-inactivated fetal bovine serum (FBS), penicillin (100 U/ml), streptomycin (100 Ag/ml), l-glutamine (2 mM), and NaHCO 3 (0.075%). Recombinant human CD40L (310-02) was purchased from Peprotech Inc (Rocky Hill, NJ). The anti-CD40-phycoerythrin (PE) (clone 5C3) and anti-mouse IgG PE isotype control antibodies were purchased from BD Pharmingen (San Diego, CA). The p50 (H-119), p52 (K-27), a-tubulin (B-7), and rabbit control Ig antibodies were obtained from Santa Cruz (Santa Cruz, CA). The p65 antibody (PC137) was obtained from Calbiochem (La Jolla, CA). The c-Rel and InBa antibodies are peptide-specific polyclonal antibodies that have been described elsewhere (Harhaj et al., 2000) .
Plasmid construction and transient expression analysis
The pCLXSN-GFP, pCLXSN-Tax, pCL-Ampho, VSV-G, pCMV4-Tax, Tax M22, Tax M47, and NF-nB-TATA luciferase constructs have been described previously Rivera-Walsh et al., 2001) . pCLXSN-Tax M22 and pCLXSN-Tax M47 were constructed by sitedirected mutagenesis using the QuikChange Site-Directed Mutagenesis kit (Stratagene, La Jolla, CA). CD40 was amplified by PCR from RSV-pCD40.neo (kindly provided by Dr. Gail Bishop, University of Iowa, Iowa City, Iowa) and cloned into the pCLXSN vector by Xho1 digestion followed by ligation with T4 ligase (New England Biolabs, Beverly, MA). The CD40 promoter (À747 to À1 relative to the translation start site) was amplified by PCR from Jurkat genomic DNA, digested with XhoI and HindIII, and ligated with pGL3. The CD40 promoter deletions were all similarly generated by PCR and cloned into pGL3. All constructs were confirmed by sequencing. The following primers were used for cloning (restriction sites are underlined): (À747, XhoI) forward, 5V-TGCCTGCTCGAGCTCGGCCTCC-TAAAGTGCTG; (À544, XhoI) forward, 5V-TGCCTGCTC-GAGGAGTTGGGAAACTCTTCCTTG; (À427, XhoI) forward, 5V-TGCCTGCTCGAGGTTCTGCCAGGATACC-TAGAG; (À327, XhoI) forward, 5V-TG CCTGCTC-GAGGTCGCAGGAAGCAGGCTAG; (À198, Xho I) forward, 5V-TGCCTGCTCGAG GGAATTAGACTTG-TGGGAATG; (À56, XhoI) forward, 5V-TGCCTGCTC-GAGGTCAGCAGAGGCCTCGCTC; (À1, Hin dIII) reverse, 5V-GCGCGCAAGCTTGGCGAGGTGAGAC-CAGGC. The NF-nB4 binding site mutant, pGL3-CD40(À747) NF-nB4 mut, was mutated from GGGAAAC-TCC to GGGAAACT by site-directed mutagenesis with a QuikChange Site-Directed Mutagenesis Kit.
Transient transfections in Jurkat cells were performed with the FuGENE 6 transfection reagent (Roche, Indianapolis, IN) following the manufacturer's instructions. Briefly, FuGENE 6 reagent was diluted with serum-free Opti-MEM (Invitrogen), mixed with DNA samples, and incubated at room temperature for 30 min. Cells were harvested 36-48 h post-transfection and cell lysates were prepared in 100 Al of 1Â Passive Lysis Buffer (Promega, Madison, WI). Luciferase activity was assayed using the Luciferase Assay system according to the manufacturer's instructions (Promega, Madison, WI). Data in graphs represent the average of at least three independent transfections. Error bars indicate the standard error of the mean (SEM) of at least three independent experiments.
Retroviral vector infections
Retroviral vector infections were performed essentially as described (Naviaux et al., 1996 ; Rivera-Walsh et al.,
2001
). Indicated retroviral vector constructs (1 Ag of either pCLXSN-GFP, Tax, or CD40) were cotransfected with pCL-Ampho (1 Ag) and VSV-g (0.15 Ag) into 293 cells (3 Â 10 5 ) in 6-well plates with FuGENE 6. After 48 h, viral supernatant was filtered through a 0.45 AM polysulfone filter (Pall-Gelman Acrodisc; Fisher Scientific, Pittsburgh, PA) and used to resuspend Jurkat or SUP-T1 cells (1 Â 10 6 ) into 6-well plates. Polybrene (8 Ag/ml; Sigma, St. Louis, MO) was added to each well, and the cells were centrifuged at 1800 rpm for 45 min. Cells were subsequently incubated at 37 8C, washed in RPMI medium the following day, and expanded for 5-7 days in the presence of G418 (1 mg/ml).
Gene array
SUP-T1 cells (1 Â 10 6 ) were infected with retroviruses using filtered supernatant from 293 cells transfected with either an empty vector (pCLXSN) or a Tax-encoding retroviral vector (pCLXSN-Tax). One week post-infection, total RNA was harvested using the Trizol reagent (Invitrogen). RNA was used for gene array analysis of TNF and TNFR genes using the GEArray Original Series Human TNF and TNFR Superfamily Gene Array kit (SuperArray, Frederick, MD). The array contains 23 common TNF and TNFR superfamily members and 2 housekeeping genes. The protocol for the gene array was performed as described by the manufacturer. Briefly, 5 Ag total RNA was converted to cDNA in the presence of biotin-16-dUTP using the AmpoLabeling-LPR kit (SuperArray). The gene array membranes were hybridized with the cDNA probes overnight at 68 8C. The membranes were washed, blocked, incubated with AP-streptavidin, washed, rinsed with phosphatase reaction buffer, incubated with CDP-Star substrate, and exposed to film. Individual spots on the arrays were quantitated from the film using a Kodak Image Station 440.
Flow cytometry
The indicated cells (5 Â 10 5 ) were incubated with 20 AL of PE-conjugated anti-CD40 antibody or isotype control antibody for 30 min in 100 Al of FACS buffer (PBS, 0.05% NaN 3 , 3% FBS) on ice. Cells were washed once with icecold FACS buffer, washed again with ice-cold PBS, and resuspended in 300 Al of 2% paraformaldehyde. Fluorescence-activated flow cytometry was performed with a FACScan 2000 (Becton Dickinson, Franklin Lakes, NJ) flow cytometer. Live cells were gated based on forward-and side-scatter properties. Single-color analyses were performed with CellQuest software (BD Biosciences).
RT-PCR
Total RNA was isolated from cells with Trizol reagent (Invitrogen) as recommended by the manufacturer. A total of 2 Ag of RNA was converted to cDNA in a reverse transcriptase (RT) reaction primed with oligo-dT (Omniscript; Qiagen, Valencia, CA). RT-PCR was performed to amplify the indicated genes in a 50 Al reaction containing 2 Al of cDNA, 1Â PCR buffer (Invitrogen), 0.25 AM of forward and reverse primers, 0.2 mM dNTP mix, 1.5 mM MgCl 2 , and 3 units of Platinum Taq polymerase (Invitrogen). PCR products were resolved by agarose gel electrophoresis. The following sets of primers were used to amplify gene products for RT-PCR reactions: glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (263 bp) forward, 5V-CCACAGTCCATG-CCATCAC, reverse 5V-GCTTCACCACCTTCTTGATG; Tax (429 bp) forward, 5V-CGG ATACCCAGTCTACGTC, reverse, 5V-GAGGTACATGCAGACAACGG; CD40 (833 bp) forward, 5V-CATGGTTCGTCTGCCTCTGC, reverse, 5V-CACTGTCTCTCCTGCACTGAG.
Western blotting
Western blotting was performed essentially as described previously (Harhaj et al., 2000) . Briefly, cytosolic and nuclear extracts were harvested from the indicated cell type. Cytosolic extracts (~20 Ag) were subjected to SDSpolyacrylamide gel electrophoresis (PAGE) at 120 V for 2.5 h. Resolved proteins were transferred to nitrocellulose membranes in transfer buffer at 120 mA for 2 h. Membranes were blocked in 5% milk in phosphate-buffered saline (PBS) with Tween 20 (0.2%, PBST), incubated with primary antibodies for 1 h (anti-InBa 1:3000 dilution, anti-a-tubulin 1:1000 dilution), washed three times with PBST, incubated with mouse or rabbit Ig-horse radish peroxidase (HRP)-conjugated antibodies (Amersham, Piscataway, NJ), washed three times with PBST, and antigenantibody complexes were detected with Western Lightning Enhanced Chemiluminescence (ECL) reagent (PerkinElmer, Boston, MA).
Nuclear extract preparation and EMSA
Small-scale nuclear extracts were prepared from cells. Briefly, cells (1 Â 10 7 ) were centrifuged, washed in PBS, and lysed in ice-cold buffer B (10 mM HEPES pH 7.9, 10 mM KCl, 0.1 mM EDTA, 0.4% IGEPAL, 1 mM dithiothreitol [DTT] , protease inhibitor cocktail (1:100), and 1 mM phenylmethylsulfonyl fluoride [PMSF] ). The supernatant was removed and transferred to new tubes after centrifugation (14,000 rpm). The nuclear pellets were washed once with buffer B, resuspended in buffer C (20 mM HEPES pH 7.9, 0.4 M NaCl, 1 mM EDTA, 1 mM DTT, and 1 mM PMSF), shaken vigorously for 10 min at 4 8C, and centrifuged for 5 min (14,000 rpm). The protein concentration of each sample was determined by the DC Protein Assay Kit (Biorad, Hercules, CA). The following sequences were used to generate double-stranded oligonucleotides for electrophoretic mobility shift assays (EMSA) and competition experiments (the NF-nB sites are underlined and the mutations are boxed): CD40 NF-nB4 site: 5V-GAATGTTCTGGGGAAACTCCTGCGCGG, CD40 NFnB4 mutant site: 5V-GAATGTTCTG ATAAAACTC-CTGCGCGG, IL-2Ra NF-nB site: 5V-CAACGGCAG GGGAATCTCCCTCTCCTT. Radiolabeling of probes was performed by a fill-in reaction with Klenow (Promega), dNTPs, and [
32 P]a-dCTP. For EMSA, nuclear extract (4 Ag) and radiolabeled probe (100,000 cpm) were incubated in reaction buffer containing dialysis buffer (25 mM HEPES pH 7.9, 10% glycerol, 100 mM KCl, 0.1 mM EDTA), poly (dI-dC) (1 Ag), and DTT (1 mM) in a total reaction volume of 15 Al for 15 min at room temperature. The DNA-protein complexes were resolved on a 5% polyacrylamide gel at 200V in 1Â TBE buffer. The gels were dried under vacuum at 80 8C for 1.5 h prior to autoradiography. Competition EMSAs were performed by adding a 50-fold molar excess of unlabeled homologous or heterologous oligonucleotides with nuclear extract on ice for 20 min prior to binding reactions. Supershifts were conducted by reacting the indicated antibodies (1 Ag) with nuclear extracts on ice for 20 min prior to binding reactions.
